PubMed:8189531
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-36 | cell_type | denotes | Central nervous system-derived cells |
| T2 | 161-164 | DNA | denotes | TAR |
| T3 | 196-199 | protein | denotes | Tat |
| T4 | 205-216 | protein | denotes | Tat protein |
| T5 | 289-309 | DNA | denotes | long terminal repeat |
| T6 | 416-437 | DNA | denotes | transcription element |
| T7 | 438-441 | DNA | denotes | TAR |
| T8 | 443-465 | cell_type | denotes | astrocytic glial cells |
| T9 | 474-477 | DNA | denotes | TAR |
| T10 | 565-568 | protein | denotes | Tat |
| T11 | 599-613 | DNA | denotes | viral enhancer |
| T12 | 680-700 | protein | denotes | transcription factor |
| T13 | 725-735 | protein | denotes | NF-kappa B |
| T14 | 775-788 | cell_type | denotes | T lymphocytes |
| T15 | 790-793 | protein | denotes | Tat |
| T16 | 826-840 | DNA | denotes | kappa B domain |
| T17 | 879-882 | DNA | denotes | TAR |
| T18 | 907-917 | cell_type | denotes | astrocytes |
| T19 | 967-999 | protein | denotes | kappa B-specific binding factors |
| T20 | 1011-1033 | cell_type | denotes | human glial astrocytes |
| T21 | 1064-1074 | protein | denotes | NF-kappa B |
| T22 | 1153-1156 | protein | denotes | Tat |
| T23 | 1193-1203 | protein | denotes | NF-kappa B |
| T24 | 1209-1223 | cell_line | denotes | Jurkat T cells |
| T25 | 1280-1321 | protein | denotes | astrocyte-derived kappa B-binding factors |
| T26 | 1352-1378 | DNA | denotes | HIV-1 long terminal repeat |
| T27 | 1424-1438 | DNA | denotes | kappa B domain |
| T28 | 1450-1453 | DNA | denotes | TAR |
| T29 | 1638-1677 | protein | denotes | central nervous system-enriched kappa B |
| T30 | 1678-1698 | protein | denotes | transcription factor |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 45-71 | NP | denotes | a kappa B-binding activity |
| C2 | 72-76 | NP | denotes | that |
| C3 | 86-135 | NP | denotes | human immunodeficiency virus type 1 transcription |
| C5 | 196-199 | NP | denotes | Tat |
| C4 | 161-199 | NP | denotes | TAR-independent transactivation by Tat |
| C6 | 201-263 | NP | denotes | The Tat protein of human immunodeficiency virus type 1 (HIV-1) |
| C7 | 289-332 | NP | denotes | long terminal repeat-directed transcription |
| C8 | 395-398 | NP | denotes | Tat |
| C10 | 509-528 | NP | denotes | HIV-1 transcription |
| C11 | 532-535 | NP | denotes | Tat |
| C9 | 474-535 | NP | denotes | TAR-independent transactivation of HIV-1 transcription by Tat |
| C12 | 595-613 | NP | denotes | the viral enhancer |
| C13 | 615-763 | NP | denotes | a kappa B domain capable of binding the prototypical form of the transcription factor nuclear factor kappa B (NF-kappa B) present in many cell types |
| C14 | 822-840 | NP | denotes | the kappa B domain |
| C15 | 1011-1033 | NP | denotes | human glial astrocytes |
| C16 | 1034-1038 | NP | denotes | that |
| C17 | 1051-1074 | NP | denotes | prototypical NF-kappa B |
| C18 | 1180-1203 | NP | denotes | prototypical NF-kappa B |
| C19 | 1331-1378 | NP | denotes | transcription of the HIV-1 long terminal repeat |
| C20 | 1420-1438 | NP | denotes | the kappa B domain |
| C21 | 1450-1504 | NP | denotes | TAR-independent transactivation of HIV-1 transcription |
| C22 | 1531-1567 | NP | denotes | an astrocyte factor-dependent manner |
| C23 | 1568-1573 | NP | denotes | which |
| R1 | C2 | C1 | coref-relat | that,a kappa B-binding activity |
| R2 | C6 | C5 | coref-ident | The Tat protein of human immunodeficiency virus type 1 (HIV-1),Tat |
| R3 | C8 | C5 | coref-ident | Tat,Tat |
| R4 | C10 | C3 | coref-ident | HIV-1 transcription,human immunodeficiency virus type 1 transcription |
| R5 | C11 | C8 | coref-ident | Tat,Tat |
| R6 | C9 | C4 | coref-ident | TAR-independent transactivation of HIV-1 transcription by Tat,TAR-independent transactivation by Tat |
| R7 | C13 | C12 | coref-appos | a kappa B domain capable of binding the prototypical form of the transcription factor nuclear factor kappa B (NF-kappa B) present in many cell types,the viral enhancer |
| R8 | C16 | C15 | coref-relat | that,human glial astrocytes |
| R9 | C18 | C17 | coref-ident | prototypical NF-kappa B,prototypical NF-kappa B |
| R10 | C19 | C7 | coref-ident | transcription of the HIV-1 long terminal repeat,long terminal repeat-directed transcription |
| R11 | C20 | C14 | coref-ident | the kappa B domain,the kappa B domain |
| R12 | C21 | C9 | coref-ident | TAR-independent transactivation of HIV-1 transcription,TAR-independent transactivation of HIV-1 transcription by Tat |
| R13 | C23 | C22 | coref-relat | which,an astrocyte factor-dependent manner |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-200 | Sentence | denotes | Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. |
| S2 | 201-333 | Sentence | denotes | The Tat protein of human immunodeficiency virus type 1 (HIV-1) is a potent activator of long terminal repeat-directed transcription. |
| S3 | 334-536 | Sentence | denotes | While in most cell types, activation requires interaction of Tat with the unusual transcription element TAR, astrocytic glial cells support TAR-independent transactivation of HIV-1 transcription by Tat. |
| S4 | 537-789 | Sentence | denotes | This alternative pathway of Tat activation is mediated by the viral enhancer, a kappa B domain capable of binding the prototypical form of the transcription factor nuclear factor kappa B (NF-kappa B) present in many cell types, including T lymphocytes. |
| S5 | 790-918 | Sentence | denotes | Tat transactivation mediated by the kappa B domain is sufficient to allow replication of TAR-deleted mutant HIV-1 in astrocytes. |
| S6 | 919-1075 | Sentence | denotes | The present study demonstrates the existence of kappa B-specific binding factors present in human glial astrocytes that differ from prototypical NF-kappa B. |
| S7 | 1076-1231 | Sentence | denotes | The novel astrocyte-derived kappa B-binding activity is retained on an HIV-1 Tat affinity column, while prototypical NF-kappa B from Jurkat T cells is not. |
| S8 | 1232-1439 | Sentence | denotes | In vitro transcription studies demonstrate that astrocyte-derived kappa B-binding factors activate transcription of the HIV-1 long terminal repeat and that this activation is dependent on the kappa B domain. |
| S9 | 1440-1615 | Sentence | denotes | Moreover, TAR-independent transactivation of HIV-1 transcription is reproduced in vitro in an astrocyte factor-dependent manner which correlates with kappa B-binding activity. |
| S10 | 1616-1750 | Sentence | denotes | The importance of the central nervous system-enriched kappa B transcription factor in the regulation of HIV-1 expression is discussed. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-22 | body_part | denotes | Central nervous system |
| T2 | 47-71 | other_name | denotes | kappa B-binding activity |
| T3 | 86-121 | virus | denotes | human immunodeficiency virus type 1 |
| T4 | 161-164 | DNA_domain_or_region | denotes | TAR |
| T5 | 196-199 | protein_molecule | denotes | Tat |
| T6 | 205-216 | protein_molecule | denotes | Tat protein |
| T7 | 220-255 | virus | denotes | human immunodeficiency virus type 1 |
| T8 | 257-262 | virus | denotes | HIV-1 |
| T9 | 289-309 | DNA_domain_or_region | denotes | long terminal repeat |
| T10 | 416-437 | DNA_family_or_group | denotes | transcription element |
| T11 | 438-441 | DNA_domain_or_region | denotes | TAR |
| T12 | 443-465 | cell_type | denotes | astrocytic glial cells |
| T13 | 474-477 | DNA_domain_or_region | denotes | TAR |
| T14 | 509-514 | virus | denotes | HIV-1 |
| T15 | 565-568 | protein_molecule | denotes | Tat |
| T16 | 599-613 | DNA_domain_or_region | denotes | viral enhancer |
| T17 | 680-700 | protein_family_or_group | denotes | transcription factor |
| T18 | 725-735 | protein_molecule | denotes | NF-kappa B |
| T19 | 775-788 | cell_type | denotes | T lymphocytes |
| T20 | 790-793 | protein_molecule | denotes | Tat |
| T21 | 826-840 | DNA_domain_or_region | denotes | kappa B domain |
| T22 | 879-882 | DNA_domain_or_region | denotes | TAR |
| T23 | 898-903 | virus | denotes | HIV-1 |
| T24 | 907-917 | cell_type | denotes | astrocytes |
| T25 | 967-999 | protein_family_or_group | denotes | kappa B-specific binding factors |
| T26 | 1011-1033 | cell_type | denotes | human glial astrocytes |
| T27 | 1064-1074 | protein_molecule | denotes | NF-kappa B |
| T28 | 1104-1128 | other_name | denotes | kappa B-binding activity |
| T29 | 1147-1152 | virus | denotes | HIV-1 |
| T30 | 1153-1156 | protein_molecule | denotes | Tat |
| T31 | 1193-1203 | protein_molecule | denotes | NF-kappa B |
| T32 | 1209-1223 | cell_line | denotes | Jurkat T cells |
| T33 | 1280-1321 | protein_family_or_group | denotes | astrocyte-derived kappa B-binding factors |
| T34 | 1352-1357 | virus | denotes | HIV-1 |
| T35 | 1424-1438 | DNA_domain_or_region | denotes | kappa B domain |
| T36 | 1450-1453 | DNA_domain_or_region | denotes | TAR |
| T37 | 1485-1490 | virus | denotes | HIV-1 |
| T38 | 1534-1567 | other_name | denotes | astrocyte factor-dependent manner |
| T39 | 1590-1614 | other_name | denotes | kappa B-binding activity |
| T40 | 1638-1660 | body_part | denotes | central nervous system |
| T41 | 1678-1698 | protein_family_or_group | denotes | transcription factor |
| T42 | 1720-1725 | virus | denotes | HIV-1 |